维普中文期刊产品整合服务
19篇 您的检索式:作者名="Gonzalez Angulo AM"
    题名 作者 年代 出处 被引量
1Dis- ease-free and overall survival after pathological complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemother- apy 显示文摘Hennessy BT Gonzalez Angulo AM Hortobagyi GN 2006Cancer2006,106,10:1
2Overview of resistance to systemic therapy in patients with breast cancer显示文摘Gonzalez Angulo AM Morales Vasquez F Hortobagyi GN 2007Adv Exp Med Biol2007,608,:1
3Incidence and ou*eome of BRCA mutations in unseleeted patients with triple Re- ceptor-Negative breast Cancer显示文摘Gonzalez Angulo AM Timms KM Liu SY 2011Clin Cancer Res2011,17,5:1
4Factors predictive of distant metastases in patients with breastcancer who have a pathologic complete response afterneoadjuvant chemotherapy 显示文摘Gonzalez - Angulo AM McGuire SE Buchholz TA 2005J Clin Oncol2005,23,28:1
5Triple - nega- tive breast cancer is not a contraindication for breast conservation 显示文摘Farrell CA Gonzalez - Angulo AM Xiudong L 2011Ann Surg Oneol2011,18,11:1
6Pre- dictors of tumor progression during neoadjuvant chemo- therapy in breast cancer 显示文摘Caudle AS Gonzalez - Angulo AM Hunt KK 2010J Clin Oncol2010,28,11:1
7Breast cancer and metastasis: onthe way toward individualized therapy 显示文摘Trap6 AP Gonzalez - Angulo AM 2012Cancer Genomics Pro-teomics2012,9,5:1
8Characterization of a naturally occurring breast cancer subset en- riched in epithelial - to - mesenehymal transition and stem cell characteristics显示文摘Hennessy BT Gonzalez - Angulo AM Stemke - Hale K 2009Cancer Res2009,69,10:1
9Overview of resistance to systemic therapy in patients with breast cancer 显示文摘Gonzalez - Angulo AM Morales - Vasquez F Hortobagyi GN 2007Adv Exp Med Biol2007,608,:1
10Overview of resistance to systemic therapy in patients with breast cancer显示文摘Gonzalez - Angulo Am Morales - Vasquez F Hortobagyi GN 2007Adv Exp Med Biol2007,608,:1
11Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer显示文摘Albert JM Gonzalez Angulo AM Guray M 2010Int J Radiat Oncol Biol Phys2010,77,5:1
12Over- view of resistance to systemic therapy in patients with breast cancer 显示文摘Gonzalez - Angulo AM Morales - Vasquez F I-Iortobagyi GN 2007Adv Exp Med Biol2007,608,:1
13Overview of resistance to systemic therapy in patients withbreast cancer显示文摘Gonzalez - Angulo AM Morales - Vasquez F HortobagyiGN 2007Adv Exp Med Biol2007,608,:1
14Overview of resistance to systemic therapy in patients with breast cancer 显示文摘Gonzalez - Angulo AM Morales - Vasquez F Hortobagyi GN 2007Adv Exp Med Biol2007,608,1:1
15Incidence and outcome of BRCA mutations in unselected patients with triple re- ceptor - negative breast cancer显示文摘Gonzalez - Angulo AM Timms KM Liu S 2011Clin Cancer Res2011,17,5:1
16Targeting the mTOR signaling network for cancer therapy显示文摘Meric- Bernstam F Gonzalez - Angulo AM 2009J Clin Oneol2009,27,13:1
17PI3 K pathway mutations and P'I~N levels in primary and metastatic breast cancer显示文摘Gonzalez - Angulo AM Ferrer- Lozano J Stemke - Hale K 2011Mol Cancer Ther2011,10,6:1
18High ERK protein expression levels correlate with shorter survival in triple - negative breast cancer patients显示文摘Bartholomeusz C Gonzalez Angulo AM Liu P 2012Oncologist2012,17,6:1
19Open label, randomized trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC (T- FEC ) versus the combination of paelitaxel and RAD001 followed by FEC ( TR - FEC ) in women with triple receptor - neg- ative breast cancer ( TNBC ) 显示文摘Gonzalez - Angulo AM Green MC 2011Clin Onco12011,29,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费